2-year follow-up from JAVELIN Lung 200, an open-label, randomized, phase 3 study of avelumab vs docetaxel in patients with platinum-treated advanced non-small cell lung cancer (NSCLC)

---

Barlesi F., Ozguroglu M., Vansteenkiste J., Spigel D., Yang J., Ishii H., ...Daha Fazla

JOURNAL FOR IMMUNOTHERAPY OF CANCER, cilt.7, 2019 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 7
• Basım Tarihi: 2019
• Dergi Adı: JOURNAL FOR IMMUNOTHERAPY OF CANCER
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır